Page results
-
This page provides general information about the procedure called lumbar decompression.
-
This information has been written for patients who have been referred for pelvic radiotherapy for a gynaecological cancer.
-
Gastro-oesophageal reflux (GOR) is the effortless regurgitation of feeds/milk. It affects over 40% of babies.
-
At UCLH, we encourage self-referral to our antenatal service, but you also have the choice to go via your GP who will make the referral for you.
-
Our vascular service has a major emphasis on endovascular (minimally invasive) treatments for vascular diseases, and this approach has largely replaced conventional open vascular surgery at UCLH.
-
Information about Lutetium-177 PSMA radionuclide therapy for metastatic or treatment-resistant prostate cancer
-
Information about the autogenic training service at the Royal London Hospital for Integrated Medicine.
-
This information is intended for patients who are receiving GnRH-a injections as part of their treatment at UCLH.
-
Dr Lynch is a consultant neurologist at the National Hospital for Neurology and Neurosurgery. He sees patients with all types of neurological disease in his general neurology clinics, and he has a particular interest in patients with inherited disorders of white matter, also called leukodystrophies
-
Coping with nausea patient information page.
File results
-
FOI/2024/0446 - Skin cancer treatment times 2019/20-2023/24
-
FOI/2024/0458 - Infected blood products, patient numbers 2019/20-2023/24
-
FOI/2024/0577 - Diffuse Large B Cell Lymphoma treatments
-
FOI/2024/0578 - Public identity insurance policies held by Fertility Clinic that cover data breaches
-
FOI/2024/0580 - Newborns taken into care from the maternity wards 2019-2023
-
FOI/2024/0581 - Weight management services/ bariatric surgery/ access to Wegovy
-
FOI/2024/0582 - SACT (systemic anti-cancer therapy) treatments for endometrial cancer
-
FOI/2024/0583 - National inpatient survey improvements/ night-time noise levels/ ward lighting/ mealtime support
-
FOI/2024/0584 - Immunology Hidradenitis Suppurativa (HS) treatments
-
FOI/2024/0586 - Subject Access Requests (SAR) and Freedom of Information (FOI) requests for 2023/24